Introduction
============

Diabetes is a metabolic disorder caused by genetic and environmental factors, which results in insulin insensitivity, insulin deficiency, and impaired biological function. The disease has become a critical health concern worldwide owing to its high prevalence and related disability and mortality.[@ref1] [@ref2] The prevalence and number of adults with diabetes has increased at a greater rate in low and middle income countries than in high income countries. This rise in prevalence has been compounded by a growing and ageing population, nearly quadrupling the number of adults with diabetes from 1980 to 2014 worldwide.[@ref3] The increase in prevalence could also be partially attributable to the new diagnostic criteria, with reduced cut-off points for blood glucose and the addition of glycated haemoglobin (HbA~1c~). The American Diabetes Association (ADA) criteria and World Health Organization (WHO) criteria are shown in [table 1](#tbl1){ref-type="table"}. The main difference between them is the inclusion of HbA~1c~ in the ADA criteria.[@ref4] [@ref5]

###### 

Diagnostic criteria for diabetes related disorders

  Disorders                    ADA diagnostic criteria                                                                                                                                                                                                                        WHO diagnostic criteria
  ---------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Self-reported diabetes       A self-reported diagnosis that was determined previously by a healthcare professional                                                                                                                                                          A self-reported diagnosis that was determined previously by a healthcare professional
  Newly diagnosed diabetes     Among participants without self-reported diabetes: fasting plasma glucose ≥126 mg/dL (7.0 mmol/L), or oral glucose tolerance test: two hour plasma glucose ≥200 mg/dL (11.1 mmol/L), or HbA~1c~ ≥6.5%                                          Among participants without self-reported diabetes: fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) or oral glucose tolerance test: two hour plasma glucose ≥200 mg/dL (11.1 mmol/L)
  Total diabetes               Sum of the number of patients with self-reported diabetes and the number of patients with newly diagnosed diabetes                                                                                                                             Sum of the number of patients with self-reported diabetes and the number of patients with newly diagnosed diabetes
  Impaired fasting glucose     Among participants without diabetes: fasting plasma glucose 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L)                                                                                                                                   Among participants without diabetes: fasting plasma glucose 110 mg/dL (6.1 mmol/L) to 125 mg/dL (6.9 mmol/L), and oral glucose tolerance test: two hour plasma glucose \<140 mg/dL (7.8 mmol/L)
  Impaired glucose tolerance   Among participants without diabetes: oral glucose tolerance test: two hour plasma glucose 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L)                                                                                                    Among participants without diabetes: fasting plasma glucose \<126 mg/dL (7.0 mmol/L), and oral glucose tolerance test: two hour plasma glucose 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L)
  Prediabetes                  Among participants without diabetes: fasting plasma glucose 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L), or oral glucose tolerance test: two hour plasma glucose 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L), or HbA~1c~ 5.7-6.4%   Among participants without diabetes: fasting plasma glucose 110 mg/dL (6.1 mmol/L) to 125 mg/dL (6.9 mmol/L), and oral glucose tolerance test: two hour plasma glucose \<140 mg/dL (7.8 mmol/L), or fasting plasma glucose \<126 mg/dL (7.0 mmol/L), and oral glucose tolerance test: two hour plasma glucose 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L)

ADA=American Diabetes Association; HbA~1c~=glycated haemoglobin; WHO=World Health Organization.

Rapid economic development in the past three decades has led to a change in lifestyle among the Chinese population, with more sedentary behaviour and a high energy/high fat diet.[@ref6] This change has resulted in more people who are overweight.[@ref7] The prevalence of diabetes in adults living in China increased from 0.67% using the WHO criteria in 1980 to 10.9% using the ADA criteria in 2013.[@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] [@ref14] Although different sampling methods and screening procedures were used between 1980 and 2013, these data show a remarkable increase. According to the diabetes atlas of the International Diabetes Federation, China has the largest number of patients with diabetes in the world. Estimates suggest that there are 113.9 million adults with diabetes living in China, accounting for 24% globally of patients with diabetes.[@ref15] Additionally, the healthcare cost associated with diabetes in China is 110 billion international dollars (purchasing power parity) in 2017.[@ref15]

China implemented healthcare reforms in 2013.[@ref16] As a result, patients with non-communicable diseases, including diabetes, could have easier access to clinical resources, thus improving the control of diabetes. Some areas have carried out a whole population project with prevention, screening, diagnosis, and management of diabetes and other non-communicable diseases. Prevention and treatment of diabetes has moved from large general hospitals to community health service centres, from simple clinical treatment to tertiary prevention of diabetes, and from simple control of blood glucose to control of weight, blood glucose, blood pressure, and blood lipids.

Our objective was to perform a cross sectional study of the prevalence of diabetes and prediabetes in mainland China, and to evaluate awareness, treatment, and control of diabetes by geographical location and subpopulation.

Methods
=======

Sampling and study population
-----------------------------

This epidemiological study, the Thyroid disorders, Iodine status and Diabetes Epidemiological survey (TIDE study), included all 31 provinces of mainland China with a sample of 75 880 people according to the age and sex composition of each community and the urban-rural ratio using the latest national census data.[@ref17] The study was conducted between 2015 and 2017.

We used a multistage, stratified sampling method to select a nationally representative sample of people aged 18 and older in the general population. The study was conducted through four stages of random sampling in urban and rural locations in parallel (supplementary fig 1). Developed, developing, and underdeveloped cities were defined based on gross domestic product per capita, concentration of commercial resources, the extent to which a city serves as a commercial hub, vitality of residents, diversity of lifestyle, and future growth potential. Six tiers of cities were categorised from developed to underdeveloped cities, each two tiers being defined as a rank and thus three ranks in all. The cities with tier 1 and new tier 1 were classified as developed cities, tiers 2 and 3 as developing cities, and tiers 4 and tier 5 as underdeveloped cities (supplementary table 1).

For urban locations, at the first stage, one city was selected from each province from all 31 provinces of China. These 31 cities were classified as 10 developed, 13 developing, and 8 underdeveloped cities. At the second stage, one district was randomly selected from each city. At the third stage, two residential communities were randomly selected from each district. At the final stage, eligible people who met the inclusion criteria and were registered as local residents were randomly selected and stratified by age and sex. The composition of age and sex of each community and urban-rural ratio were decided based on China's 2010 national census data.[@ref17] Parallel random sampling was performed in rural locations (supplementary fig 1).

For adult respondents, the inclusion criteria were age 18 or older, living in the selected community for at least five years, and not pregnant. At least 1000 people from each ethnic minority were recruited in four autonomous regions. Finally, Tibetan, Uyghur, Hui, and Zhuang ethnic groups were analysed. A total of 80 937 participants completed the survey and the overall response rate was 92.1%. Our analysis included 75 880 participants after excluding 5057 people with missing information on sex, age, plasma glucose, or HbA~1c~ (supplementary fig 1). Research protocols were approved by the medical ethics committee of China Medical University. All participants provided written informed consent after receiving a thorough explanation of the research procedures.

Demographic and behavioural assessment
--------------------------------------

For each participant, a trained interviewer used a detailed questionnaire to collect information about demographic variables, behavioural factors, family history of chronic diseases, and personal medical history. Current smoking was defined as having smoked at least 100 cigarettes in one's life and currently smoking cigarettes. Occasional smokers were defined as currently smoking fewer than 20 cigarettes a day. Regular smokers were defined as currently smoking more than 20 cigarettes a day.

Anthropometric and clinical assessment
--------------------------------------

Body weight, height, waist circumference, and blood pressure were measured by trained health workers according to standard protocols. Body mass index was calculated by dividing body weight in kg by the square of height in metres. Blood pressure was measured by an electronic blood pressure monitor (Omron HEM-7430, Omron Corporation) on the non-dominant arm twice consecutively with a 10 minute interval between measurements and with the participant in a seated position after five minutes of rest. We defined central obesity as a waist circumference of 90 cm or greater for men and 80 cm or greater for women. We defined generalised overweight as a body mass index of 25 to less than 30, and defined obesity as a body mass index of 30 or higher for both men and women.[@ref18] Detailed information for the anthropometric and clinical methods and quality control is given in supplementary appendix 1.

Biochemical assessment
----------------------

Blood samples were collected from all participants after an overnight fast of at least 10 hours. Serum samples were used for the measurements of fasting plasma glucose levels and two hour plasma glucose levels after carrying out an oral 75 g glucose tolerance test. HbA~1c~ was measured in venous blood samples by high performance liquid chromatography (Bio-Rad VARIANT II Haemoglobin Analyzer). In people with self-reported diabetes, only fasting plasma glucose and HbA~1c~ were measured. Fasting plasma glucose, two hour plasma glucose levels, serum total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides were measured using an automatic biochemical analyser (Mindray BS-180 Analyzer).

This biochemical assessment of diabetes differs from the testing strategy used in practice. In the absence of unequivocal hyperglycaemia or symptoms, assessment should be confirmed by repeat testing. We carried out only one reading on measured glucose or HbA~1c~, but this approach has been widely used by previous national epidemiologic surveys.[@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13]

Outcome assessment
------------------

Diagnostic criteria for diabetes related disorders are presented in [table 1](#tbl1){ref-type="table"}. Treatment was defined as the proportion of individuals taking drugs for diabetes among those diagnosed with the disease. Control was defined as the proportion of individuals with an HbA~1c~concentration of less than 7.0% among patients with diabetes who were taking medication.

Statistical analysis
--------------------

To account for the complex sampling design of this study, we used SUDAAN software (Research Triangle Institute) to obtain estimates of prevalence and the standard errors according to the Taylor linearisation method. Estimates were weighted to reflect age, sex, and urban-rural, distribution of provinces of the adults living in China. Weighting coefficients were derived from the 2010 Chinese population census data, and the sampling scheme of our survey was to obtain a national estimate. Briefly, the weighting coefficient was the inverse of the adjusted probability of obtaining the data for the respondent; each individual case in the analysis was assigned a certain coefficient (individual weight), by which it was multiplied to represent the actual population with the same characteristics of sex, age, province, and location. Standard errors were calculated with appropriate statistical techniques with data from the complex survey design. Categorical data are presented as percentages and 95% confidence intervals and were analysed by a χ^2^ test or Fisher's exact test, as appropriate. Continuous data are described with means and 95% CIs. A binomial logit regression was used to examine the association of risk factors with the odds of total diabetes and prediabetes. A P value less than 0.05 was considered statistically significant. All statistical analyses were conducted using the SAS system, version 9.3 (SAS Institute Inc, Cary, NC) and SUDAAN software, version 10.0 (Research Triangle Institute).

Patient and public involvement
------------------------------

This research was done without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.

Results
=======

The general characteristics and metabolic risk factors of the study population are presented in [table 2](#tbl2){ref-type="table"} and supplementary figure 2. The overall standardised prevalence of total diabetes, self-reported diabetes, and newly diagnosed diabetes using the ADA criteria were 12.8% (95% confidence interval 12.0% to 13.6%), 6.0% (5.4% to 6.7%), and 6.8% (6.1% to 7.4%), respectively, in Chinese adults. The prevalence of total diabetes was higher in men than in women. The standardised prevalence of prediabetes was 35.2% (33.5% to 37.0%) in Chinese adults, diagnosed by the ADA criteria ([table 3](#tbl3){ref-type="table"} and supplementary table 2). No significant differences in the prevalence of diabetes and prediabetes were found between urban and rural residents. The weighted prevalence of total diabetes diagnosed by the WHO criteria was 11.2% in 2017. The prevalence of diabetes varied with different diagnostic criteria.

###### 

General characteristics of adults living in mainland China. Data are percentage (95% confidence interval) unless indicated otherwise

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics\                                Overall (n=75 880)       Sex                                               Urbanisation                            
  ----------------------------------------------- ------------------------ ------------------------ ------------------------ -------------- ------------------------ ------------------------
  Mean age at survey (95% CI)                     42.8 (41.9 to 43.7)      42.6 (41.8 to 43.5)      43.0 (42.1 to 43.9)                     41.4 (40.5 to 42.4)      44.3 (43.5 to 45.1)

  Ethnicity:                                                                                                                                                         

   Han                                            95.4 (93.5 to 96.8)      95.3 (93.4 to 96.7)      95.6 (93.6 to 97.0)                     96.7 (86.9 to 99.2)      94.0 (78.7 to 98.5)

   Tibetan                                        0.2 (0.1 to 0.5)         0.2 (0.1 to 0.5)         0.2 (0.1 to 0.5)                        0.1 (0.01 to 0.7)        0.3 (0.04 to 2.3)

   Uyghur                                         1.3 (1.1 to 1.6)         1.4 (1.1 to 1.7)         1.3 (1.1 to 1.5)                        1.2 (0.2 to 8.7)         1.5 (0.2 to 10.9)

   Hui                                            0.3 (0.1 to 1.3)         0.3 (0.04 to 1.4)        0.3 (0.1 to 1.3)                        0.04 (0.01 to 0.3)       0.5 (0.1 to 3.7)

   Zhuang                                         2.8 (1.6 to 4.8)         2.9 (1.7 to 4.8)         2.7 (1.6 to 4.8)                        2.0 (0.3 to 13.9)        3.7 (0.5 to 23.7)

  Income per year (¥):                                                                                                                                               

   ≤30 000                                        44.8 (38.2 to 51.7)      41.3 (35.1 to 47.9)      48.4 (41.3 to 55.6)                     31.0 (26.4 to 35.9)      59.7 (53.9 to 65.3)

   \>30 000                                       55.2 (48.3 to 61.8)      58.7 (52.2 to 64.9)      51.6 (44.4 to 58.7)                     69.1 (64.1 to 73.6)      40.3 (34.7 to 46.1)

  Education:                                                                                                                                                         

   Less than high school                          43.7 (36.5 to 51.2)      40.4 (33.6 to 47.6)      47.1 (39.3 to 55.0)                     28.2 (23.2 to 33.8)      60.5 (56.2 to 64.7)

   High school and above                          56.3 (48.8 to 63.5)      59.6 (52.4 to 66.4)      52.9 (45.1 to 60.7)                     71.8 (66.2 to 76.8)      39.5 (35.3 to 43.8)

  Cigarette smoking:                                                                                                                                                 

   Current non-smoker                             73.6 (72.3 to 74.8)      50.0 (47.5 to 52.5)      97.5 (96.8 to 98.1)                     75.5 (73.7 to 77.2)      71.5 (69.3 to 73.6)

   Occasional smoker                              4.0 (3.6 to 4.4)         7.0 (6.3 to 7.7)         0.9 (0.7 to 1.2)                        4.3 (3.6 to 5.1)         3.6 (3.0 to 4.3)

   Regular smoker                                 22.5 (21.2 to 23.8)      43.1 (40.4 to 45.8)      1.6 (1.1 to 2.2)                        20.3 (18.5 to 22.2)      24.9 (22.5 to 27.4)

  Family history of diabetes                      16.4 (13.9 to 19.3)      15.5 (13.2 to 18.1)      17.4 (14.6 to 20.6)                     22.0 (19.1 to 25.1)      10.4 (8.8 to 12.3)

  Physical examination:                                                                                                                                              

   Mean body mass index (95% CI)                  24.0 (23.9 to 24.1)      24.6 (24.4 to 24.8)      23.4 (23.2 to 23.6)                     23.9 (23.6 to 24.3)      24.1 (23.8 to 24.4)

   Body mass index \<25                           62.9 (61.5 to 64.2)      56.1 (54.2 to 58.0)      69.7 (67.8 to 71.6)                     63.9 (60.2 to 67.3)      61.8 (58.5 to 65.0)

   Body mass index 25 to \<30                     30.9 (29.8 to 32.0)      36.3 (34.8 to 37.9)      25.3 (23.7 to 27.0)                     30.0 (27.6 to 32.6)      31.8 (29.5 to 34.2)

   Body mass index ≥30                            6.3 (5.9 to 6.6)         7.6 (7.0 to 8.2)         4.9 (4.6 to 5.3)                        6.1 (5.1 to 7.4)         6.4 (5.4 to 7.5)

   Mean waist circumference (95% CI; cm)          83.2 (82.4 to 84.0)      86.6 (85.8 to 87.5)      79.7 (78.8 to 80.6)                     82.7 (81.6 to 83.8)      83.7 (82.1 to 85.3)

   Mean heart rate (95% CI; counts per min        79.8 (79.2 to 80.5)      78.9 (78.2 to 79.6)      80.8 (80.1 to 81.5)                     80.0 (78.7 to 81.4)      79.6 (78.5 to 80.8)

   Mean systolic blood pressure (95% CI; mm Hg)   126.3 (124.9 to 127.7)   129.9 (128.8 to 131.0)   122.7 (120.9 to 124.4)                  124.1 (122.8 to 125.5)   128.7 (126.9 to 130.5)

   Mean diastolic blood pressure 95% CI; mm Hg)   78.3 (77.2 to 79.5)      80.7 (79.3 to 82.1)      76.0 (74.9 to 77.0)                     77.3 (76.0 to 78.6)      79.5 (77.4 to 81.5)

  Laboratory tests (mean (95% CI)):                                                                                                                                  

   Cholesterol (mmol/L)                           4.8 (4.7 to 4.8)         4.8 (4.8 to 4.9)         4.8 (4.7 to 4.8)                        4.8 (4.7 to 4.9)         4.7 (4.6 to 4.9)

   Low density lipoprotein (mmol/L)               2.8 (2.8 to 2.9)         2.9 (2.8 to 3.0)         2.8 (2.7 to 2.8)                        2.8 (2.7 to 2.9)         2.8 (2.7 to 3.0)

   High density lipoprotein (mmol/L)              1.5 (1.5 to 1.5)         1.4 (1.4 to 1.4)         1.6 (1.5 to 1.6)                        1.5 (1.4 to 1.5)         1.5 (1.4 to 1.5)

   Triglycerides (mmol/L)                         1.6 (1.5 to 1.6)         1.8 (1.7 to 1.8)         1.4 (1.3 to 1.4)                        1.5 (1.5 to 1.6)         1.6 (1.5 to 1.7)

   Fasting plasma glucose (mmol/L)                5.4 (5.4 to 5.5)         5.5 (5.4 to 5.6)         5.3 (5.3 to 5.4)                        5.4 (5.3 to 5.5)         5.5 (5.3 to 5.6)

   Two hour plasma glucose (mmol/L)               6.5 (6.4 to 6.6)         6.5 (6.4 to 6.6)         6.5 (6.4 to 6.6)                        6.5 (6.4 to 6.7)         6.5 (6.3 to 6.7)

   HbA~1c~                                        5.6 (5.4 to 5.7)         5.6 (5.5 to 5.7)         5.5 (5.4 to 5.6)                        5.5 (5.3 to 5.7)         5.6 (5.6 to 5.7)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

100=£12; €13; \$14.

###### 

Age and sex standardised prevalence of diabetes, prediabetes, and risk factors among adults living in mainland China

  Characteristics               No of participants   Percentage estimated prevalence (95% confidence interval)                                                                     
  ----------------------------- -------------------- ----------------------------------------------------------- --------------------- --------------------- --------------------- ----------------------
  Overall                       75 880               6.0 (5.4 to 6.7)                                            8.7 (8.1 to 9.3)      11.2 (10.5 to 11.9)   12.8 (12.0 to 13.6)   35.2 (33.5 to 37.0)
  Sex:                                                                                                                                                                             
   Men                          36 819               6.4 (5.6 to 7.2)                                            9.7 (8.9 to 10.5)     12.1 (11.3 to 13.0)   13.7 (12.8 to 14.7)   37.0 (35.2 to 38.9)
   Women                        39 061               5.6 (5.1 to 6.2)                                            7.7 (7.1 to 8.3)      10.3 (9.5 to 11.1)    11.8 (10.9 to 12.7)   33.4 (31.6 to 35.3)
   P for difference             ---                  0.01                                                        \<0.001               \<0.001               \<0.001               \<0.001
  Urbanisation:                                                                                                                                                                    
   Urban                        40 560               7.1 (6.6 to 7.7)                                            9.6 (9.0 to 10.3)     12.2 (11.4 to 13.1)   13.7 (12.7 to 14.7)   34.6 (31.6 to 37.7)
   Rural                        35 320               5.0 (4.3 to 5.9)                                            7.9 (7.0 to 8.9)      10.3 (9.2 to 11.6)    12.0 (10.7 to 13.3)   35.8 (32.2 to 39.6)
   P for difference             ---                  0.08                                                        0.49                  0.76                  0.92                  0.29
  Age group:                                                                                                                                                                       
   18-29                        17 873               0.8 (0.5 to 1.2)                                            1.3 (0.9 to 1.8)      1.5 (1.0 to 2.1)      2.0 (1.5 to 2.7)      20.2 (18.2 to 22.40)
   30-39                        15 082               2.6 (2.1 to 3.2)                                            4.2 (3.6 to 4.8)      5.4 (4.6 to 6.3)      6.3 (5.4 to 7.3)      29.9 (27.4 to 32.5)
   40-49                        16 686               4.8 (4.1 to 5.7)                                            8.2 (7.4 to 9.1)      10.6 (9.6 to 11.6)    12.1 (11.1 to 13.3)   40.0 (38.0 to 41.9)
   50-59                        12 736               10.6 (9.6 to 11.7)                                          15.0 (14.1 to 16.1)   18.9 (17.8 to 20.1)   21.1 (19.8 to 22.6)   47.1 (44.9 to 49.4)
   60-69                        8205                 14.9 (12.8 to 17.3)                                         19.7 (17.6 to 22.0)   25.5 (23.3 to 27.9)   28.8 (26.5 to 31.3)   47.8 (45.0 to 50.6)
   ≥70                          5298                 16.5 (13.8 to 19.5)                                         21.4 (18.6 to 24.4)   28.8 (25.7 to 32.1)   31.8 (28.8 to 35.1)   47.6 (44.3 to 51.0)
   P for trend                  ---                  \<0.001                                                     \<0.001               \<0.001               \<0.001               \<0.001
  Ethnicity:                                                                                                                                                                       
   Han                          68 064               6.1 (5.5 to 6.8)                                            8.8 (8.2 to 9.5)      11.3 (10.6 to 12.0)   12.8 (12.0 to 13.7)   35.4 (33.6 to 37.3)
   Tibetan                      2034                 1.5 (0.6 to 3.3)                                            1.9 (0.7 to 5.0)      4.2 (3.8 to 4.6)      6.5 (6.1 to 6.9)      34.4 (26.3 to 43.6)
   Uyghur                       2159                 4.6 (4.2 to 5.0)                                            7.8 (6.4 to 9.5)      9.1 (7.4 to 11.0)     11.5 (9.6 to 13.6)    20.2 (12.6 to 30.7)
   Hui                          1661                 1.8 (0.5 to 7.0)                                            4.4 (2.6 to 7.3)      5.4 (3.6 to 8.1)      6.3 (3.9 to 9.9)      36.2 (31.3 to 41.4)
   Zhuang                       1962                 3.8 (1.5 to 9.1)                                            5.6 (2.5 to 12.3)     10.0 (6.6 to 14.7)    11.4 (7.7 to 16.5)    35.5 (34.6 to 36.4)
   P for difference             ---                  \<0.001                                                     \<0.001               \<0.001               \<0.001               0.005
  Region:                                                                                                                                                                          
   South                        6882                 5.8 (3.0 to 10.7)                                           8.3 (5.3 to 12.7)     11.6 (8.2 to 16.1)    12.8 (9.5 to 16.9)    35.1 (32.7 to 37.1)
   North                        12 112               6.6 (5.2 to 8.4)                                            9.2 (7.7 to 10.9)     11.4 (9.7 to 13.4)    14.2 (12.5 to 16.2)   37.4 (33.0 to 42.0)
   East                         17 206               5.9 (5.1 to 6.7)                                            8.2 (7.5 to 9.1)      10.7 (9.9 to 11.5)    12.2 (10.9 to 13.5)   33.7 (30.1 to 37.5)
   Central                      7823                 6.6 (5.5 to 7.9)                                            8.7 (7.8 to 9.6)      10.5 (9.8 to 11.2)    12.3 (11.7 to 12.8)   38.0 (35.4 to 40.7)
   Southwest                    11 347               4.7 (3.7 to 6.1)                                            8.8 (7.5 to 10.4)     11.9 (10.0 to 14.2)   13.3 (10.8 to 16.3)   37.7 (31.8 to 44.1)
   Northwest                    13 147               5.7 (4.4 to 7.4)                                            8.2 (7.0 to 9.6)      10.7 (9.6 to 12.0)    12.1 (10.9 to 13.6)   31.7 (28.3 to 35.3)
   Northeast                    7363                 6.8 (4.8 to 9.6)                                            10.0 (7.7 to 12.8)    12.7 (10.2 to 15.6)   12.9 (10.5 to 15.8)   31.3 (24.7 to 38.7)
   P for difference             ---                  0.25                                                        0.27                  0.33                  0.10                  0.04
  Income per year (¥):                                                                                                                                                             
   ≤30 000                      32 339               5.9 (5.2 to 6.6)                                            8.7 (7.9 to 9.5)      11.3 (10.4 to 12.3)   12.9 (11.9 to 14.0)   35.7 (33.8 to 37.7)
   \>30 000                     42 552               6.3 (5.7 to 7.0)                                            8.9 (8.3 to 9.6)      11.4 (10.7 to 12.1)   12.9 (12.0 to 13.8)   35.0 (32.9 to 37.1)
   P for difference             ---                  \<0.001                                                     \<0.001               \<0.001               0.001                 0.01
  Education:                                                                                                                                                                       
   Less than high school        34 856               5.8 (5.1 to 6.7)                                            8.8 (7.9 to 9.8)      11.3 (10.3 to 12.5)   12.9 (11.8 to 14.1)   36.9 (34.2 to 39.7)
   High school and above        40 729               6.6 (6.1 to 7.3)                                            9.0 (8.4 to 9.6)      11.5 (10.8 to 12.2)   13.2 (12.5 to 14.0)   34.6 (32.7 to 36.5)
   P for difference             ---                  \<0.001                                                     \<0.001               \<0.001               \<0.001               \<0.001
  Cigarette smoking:                                                                                                                                                               
   Current non-smoker           55 958               6.2 (5.5 to 6.9)                                            8.7 (8.1 to 9.4)      11.4 (10.7 to 12.1)   12.9 (12.1 to 13.7)   35.0 (33.2 to 36.9)
   Occasional smoker            2626                 6.2 (4.6 to 8.3)                                            9.9 (8.6 to 11.2)     12.0 (10.9 to 13.3)   13.5 (12.2 to 14.9)   35.2 (31.5 to 39.0)
   Regular smoker               17 246               6.7 (5.7 to 7.9)                                            10.0 (8.7 to 11.5)    11.9 (10.4 to 13.6)   13.6 (11.9 to 15.4)   34.2 (31.4 to 37.1)
   P for trend                  ---                  0.38                                                        0.08                  0.42                  0.33                  0.50
  Family history of diabetes:                                                                                                                                                      
   Yes                          12 348               15.3 (14.1 to 16.5)                                         18.6 (17.4 to 19.9)   21.6 (20.2 to 23.2)   23.3 (21.8 to 25.0)   33.2 (30.9 to 35.4)
   No                           63 503               4.5 (4.1 to 5.0)                                            7.1 (6.6 to 7.6)      9.5 (8.9 to 10.1)     11.0 (10.3 to 11.7)   35.4 (33.6 to 37.2)
   P for difference             ---                  \<0.001                                                     \<0.001               \<0.001               \<0.001               \<0.001
  Body mass index:                                                                                                                                                                 
   \<25                         47 749               5.0 (4.4 to 5.7)                                            6.8 (6.2 to 7.5)      8.8 (8.0 to 9.6)      10.0 (9.2 to 10.9)    33.0 (31.1 to 35.0)
   25 to \<30                   23 178               7.4 (6.7 to 8.2)                                            10.8 (10.0 to 11.7)   13.8 (13.0 to 14.7)   15.6 (14.7 to 16.6)   38.9 (36.6 to 41.4)
   ≥30                          4786                 9.8 (8.8 to 10.9)                                           15.3 (14.4 to 16.2)   20.1 (18.9 to 21.5)   23.0 (21.8 to 24.2)   43.1 (40.3 to 46.0)
   P for trend                  ---                  \<0.001                                                     \<0.001               \<0.001               0.03                  \<0.001
  Waist circumference (cm):                                                                                                                                                        
   Men ≥90, women ≥80           41 736               7.4 (6.7 to 8.3)                                            11.1 (10.3 to 11.9)   14.2 (13.4 to 15.2)   16.2 (15.2 to 17.1)   38.9 (36.9 to 40.9)
   Men \<90, women \<80         33 827               4.4 (3.8 to 5.1)                                            6.2 (5.5 to 7.0)      8.0 (7.2 to 8.9)      9.3 (8.3 to 10.3)     33.1 (31.2 to 35.1)
   P for difference             ---                  \<0.001                                                     \<0.001               \<0.001               \<0.001               \<0.001

100=£12; €13; \$14. Some values were missing in the total population: 989 for income, 295 for education, 50 for cigarette smoking, 29 for family history of diabetes, 167 for body mass index, and 317 for waist circumference.

In many subpopulations, the prevalence of total diabetes and prediabetes was higher among men, among people with a low education level and low family income, among those who were overweight and obese, and among those who reported a family history of diabetes. Han ethnic participants had the highest prevalence of total diabetes in comparison with Uyghur, Zhuang, Tibetan, and Hui participants. The prevalence of total diabetes and prediabetes increased with age in both men and women and increased more sharply after age 50 ([table 3](#tbl3){ref-type="table"} and [fig 1](#f1){ref-type="fig"}).

![Prevalence, awareness, treatment, and control of diabetes diagnosed by the American Diabetes Association criteria among study participants](liyo054529.f1){#f1}

Regional variations in the prevalence of total diabetes were found, with the highest prevalence in the north, followed by the southwest, northeast, south, central, east, and northwest ([table 3](#tbl3){ref-type="table"}). Supplementary figure 3 illustrates the geographical variation in the prevalence of total diabetes and prediabetes at the provincial level, stratified into quintiles. The prevalence of total diabetes varied from 6.2% in Guizhou to 19.9% in Inner Mongolia (supplementary table 3).

Awareness, treatment, and control of diabetes and risk factors in adults living in China, standardised for age and sex, are presented in [table 4](#tbl4){ref-type="table"}. The proportion of patients who were aware of their diabetes and were treated was higher in the older population, and the rate of awareness of diabetes was significantly higher in urban than in rural residents ([table 4](#tbl4){ref-type="table"} and [fig 1](#f1){ref-type="fig"}). The proportion of patients who controlled their HbA~1c~ levels well was higher in younger patients and in urban residents.

###### 

Age and sex standardised awareness, treatment, and control of diabetes and risk factors among adults living in mainland China

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables\                    Awareness of diabetes                         Treatment of diabetes          Control of diabetes             
  ----------------------------- ----------------------- --------------------- ----------------------- ------ --------------------- -- ------ ---------------------
  Overall                       9772                    43.3 (39.2 to 47.5)                           4464   49.0 (44.5 to 53.4)      2792   49.4 (39.4 to 59.4)

  Sex:                                                                                                                                       

   Men                          5093                    42.0 (35.6 to 48.7)                           2316   52.6 (47.5 to 57.5)      1503   48.0 (37.1 to 59.1)

   Women                        4679                    44.5 (41.5 to 47.6)                           2148   45.3 (38.8 to 51.9)      1289   50.9 (38.8 to 62.8)

   P for difference             ---                     0.25                                          ---    0.10                     ---    0.36

  Urbanisation:                                                                                                                              

   Urban                        5561                    47.5 (42.9 to 52.0)                           2751   51.6 (46.9 to 56.2)      1746   53.9 (41.9 to 65.5)

   Rural                        4211                    38.0 (33.1 to 43.2)                           1713   45.5 (38.6 to 52.7)      1046   47.4 (42.6 to 52.2)

   P for difference             ---                     0.02                                          ---    0.90                     ---    0.003

  Age group:                                                                                                                                 

   18-29                        344                     38.4 (28.7 to 49.1)                           118    31.0 (20.5 to 43.9)      38     67.7 (32.3 to 90.2)

   30-39                        903                     41.6 (37.0 to 46.5)                           355    38.1 (31.9 to 44.7)      139    52.2 (42.5 to 61.7)

   40-49                        1916                    39.2 (34.2 to 44.4)                           768    55.9 (49.1 to 62.6)      441    37.9 (31.2 to 45.0)

   50-59                        2549                    50.1 (46.3 to 53.8)                           1167   65.5 (62.4 to 68.5)      771    39.2 (34.2 to 44.6)

   60-69                        2317                    51.8 (45.5 to 57.9)                           1171   66.3 (60.6 to 71.6)      794    39.7 (36.1 to 43.4)

   ≥70                          1743                    51.8 (46.8 to 56.7)                           885    64.9 (57.3 to 71.7)      609    45.5 (40.3 to 50.8)

   P for trend                  ---                     \<0.001                                       ---    0.003                    ---    0.03

  Ethnicity:                                                                                                                                 

   Han                          9076                    44.0 (39.8 to 48.2)                           4210   49.1 (44.6 to 53.6)      2647   49.5 (39.5 to 59.6)

   Tibetan                      129                     28.3 (14.9 to 47.2)                           48     43.4 (29.4 to 58.6)      22     24.3 (24.3 to 24.3)

   Uyghur                       233                     34.2 (28.8 to 40.1)                           92     32.5 (10.3 to 66.9)      45     36.9 (32.2 to 41.8)

   Hui                          112                     36.7 (23.7 to 51.9)                           36     66.7 (53.0 to 78.0)      23     43.9 (40.9 to 47.0)

   Zhuang                       222                     27.1 (8.5 to 59.6)                            78     60.6 (40.6 to 77.6)      55     40.8 (36.4 to 45.3)

   P for difference             ---                     0.047                                         ---    0.86                     ---    0.12

  Region:                                                                                                                                    

   South                        1003                    45.4 (31.8 to 59.8)                           448    46.9 (39.3 to 54.7)      219    67.0 (51.4 to 79.6)

   North                        1820                    39.0 (33.9 to 44.5)                           836    50.7 (37.6 to 63.7)      548    51.3 (44.7 to 57.8)

   East                         2216                    41.8 (36.8 to 46.9)                           1012   39.8 (33.4 to 46.5)      580    43.0 (32.3 to 54.4)

   Central                      952                     48.6 (42.2 to 55.1)                           529    49.0 (40.3 to 57.7)      355    41.3 (40.7 to 41.9)

   Southwest                    1374                    33.2 (26.1 to 41.2)                           528    46.8 (37.7 to 56.2)      355    53.3 (43.1 to 63.3)

   Northwest                    1451                    43.8 (35.6 to 52.3)                           612    58.0 (50.4 to 65.3)      408    41.0 (31.7 to 51.0)

   Northeast                    956                     47.9 (40.3 to 55.6)                           499    61.4 (49.2 to 72.3)      327    40.8 (30.9 to 51.5)

   P for difference             ---                     0.42                                          ---    0.29                     ---    0.02

  Income per year (¥):                                                                                                                       

   ≤30 000                      4652                    43.1 (38.4 to 47.9)                           2089   50.7 (42.2 to 59.1)      1301   51.7 (47.6 to 55.8)

   \>30 000                     5012                    43.1 (38.4 to 47.9)                           2325   49.6 (42.9 to 56.4)      1473   45.5 (37.3 to 53.9)

   P for difference             ---                     0.59                                          ---    0.69                     ---    0.12

  Education:                                                                                                                                 

   Less than high school        5708                    44.3 (39.4 to 49.3)                           2562   46.6 (42.0 to 51.2)      1669   44.7 (37.0 to 52.7)

   High school and above        4018                    43.9 (39.3 to 48.6)                           1880   50.9 (45.8 to 56.0)      1119   54.6 (44.1 to 64.8)

   P for difference             ---                     0.34                                          ---    0.02                     ---    0.045

  Cigarette smoking:                                                                                                                         

   Current non-smoker           6791                    44.4 (39.6 to 49.3)                           3216   51.0 (45.4 to 56.7)      2004   50.9 (39.8 to 62.0)

   Occasional smoker            304                     38.5 (30.8 to 46.7)                           135    44.7 (37.7 to 52.1)      84     29.5 (20.5 to 40.5)

   Regular smoker               2487                    44.5 (34.9 to 54.5)                           1105   40.4 (35.6 to 45.3)      704    42.9 (32.2 to 54.4)

   P for trend                  ---                     0.98                                          ---    \<0.001                  ---    0.01

  Family history of diabetes:                                                                                                                

   Yes                          2623                    59.3 (55.8 to 62.8)                           1640   56.4 (47.9 to 64.5)      1080   49.2 (38.1 to 60.4)

   No                           7138                    36.7 (32.6 to 41.0)                           2815   43.6 (38.7 to 48.6)      1709   46.8 (39.6 to 54.1)

   P for difference             ---                     \<0.001                                       ---    0.23                     ---    0.9

  Body mass index:                                                                                                                           

   \<25                         4310                    43.1 (38.0 to 48.3)                           2078   51.6 (42.6 to 60.5)      1243   57.4 (51.8 to 62.9)

   25 to \<30                   4289                    45.8 (39.5 to 52.3)                           1911   46.9 (40.2 to 53.8)      1245   39.7 (30.6 to 49.5)

   ≥30                          1142                    41.2 (36.8 to 45.7)                           462    51.0 (43.9 to 58.1)      298    49.2 (39.7 to 58.8)

   P for trend                  ---                     0.40                                          ---    0.93                     ---    0.004

  Waist circumference (cm)                                                                                                                   

   Men ≥90, women ≥80           6466                    44.1 (39.8 to 48.5)                           2924   48.8 (42.3 to 55.3)      1869   42.3 (33.5 to 51.7)

   Men \<90, women \<80         3250                    42.3 (36.8 to 48.0)                           1505   50.0 (41.3 to 58.6)      905    57.4 (49.4 to 65.0)

   P for difference             ---                     0.54                                          ---    0.14                     ---    0.44
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

100=£12; €13; \$14. Some values were missing in the total population: 989 for income, 295 for education, 50 for cigarette smoking, 29 for family history of diabetes, 167 for body mass index, and 317 for waist circumference.

In the multivariable logit models, male sex; older age; family history of diabetes; overweight and obesity; central obesity; each 10 mm Hg increase in systolic blood pressure; each 10 beats/min in heart rate; and raised total cholesterol, low density lipoprotein, and triglycerides levels were significantly associated with increased risks of total diabetes and prediabetes ([table 5](#tbl5){ref-type="table"}). Hui ethnic participants had a lower risk of total diabetes than ethnic Han participants.

###### 

Risk factors for total diabetes and prediabetes diagnosed by the American Diabetes Association criteria among adults living in mainland China. Data are odds ratio (95% confidence interval)

  Variable                                        Total diabetes        Prediabetes
  ----------------------------------------------- --------------------- ---------------------
  Men                                             1.29 (1.14 to 1.45)   1.18 (1.08 to 1.28)
  Age, per 10 year increment                      2.20 (2.05 to 2.36)   1.54 (1.46 to 1.61)
  Urban residence                                 1.19 (0.87 to 1.62)   1.03 (0.75 to 1.42)
  Ethnicity (reference: Han):                                           
   Tibetan                                        0.58 (0.14 to 2.37)   0.93 (0.34 to 2.52)
   Uyghur                                         0.58 (0.26 to 1.30)   0.31 (0.09 to 1.06)
   Hui                                            0.64 (0.45 to 0.90)   1.13 (0.76 to 1.68)
   Zhuang                                         1.37 (0.78 to 2.39)   1.19 (1.02 to 1.39)
  Region (reference: South):                                            
   North                                          1.24 (0.77 to 2.01)   1.31 (1.03 to 1.66)
   East                                           1.06 (0.64 to 1.76)   1.06 (0.82 to 1.37)
   Central                                        1.06 (0.67 to 1.69)   1.25 (1.04 to 1.50)
   Southwest                                      1.48 (0.79 to 2.78)   1.41 (0.98 to 2.02)
   Northwest                                      1.14 (0.72 to 1.80)   1.14 (0.91 to 1.43)
   Northeast                                      0.74 (0.47 to 1.18)   0.83 (0.57 to 1.19)
  Family history of diabetes                      3.06 (2.74 to 3.42)   1.27 (1.16 to 1.39)
  Less than high school education                 1.11 (0.99 to 1.23)   1.08 (0.96 to 1.21)
  Income ≤¥30 000 RMB a year                      1.13 (1.01 to 1.27)   1.03 (0.97 to 1.10)
  Current smoking                                 0.94 (0.85 to 1.05)   0.97 (0.90 to 1.05)
  Weight:                                                               
   Overweight                                     1.46 (1.26 to 1.69)   1.25 (1.13 to 1.38)
   Obesity                                        2.62 (2.30 to 2.98)   1.79 (1.56 to 2.06)
   Central obesity                                1.49 (1.32 to 1.69)   1.22 (1.11 to 1.35)
  Systolic blood pressure per 10 mm Hg increase   1.12 (1.10 to 1.15)   1.05 (1.02 to 1.07)
  Cholesterol                                                           
   Total per 1 mmol/L                             1.19 (1.07 to 1.34)   1.15 (1.05 to 1.25)
   Low density lipoprotein per mmol/L             1.12 (1.00 to 1.25)   1.16 (1.06 to 1.27)
   High density lipoprotein per mmol/L            0.64 (0.53 to 0.78)   0.89 (0.78 to 1.01)
   Triglycerides per mmol/L                       1.16 (1.10 to 1.22)   1.05 (1.00 to 1.11)
  Heart rate, per increase of 10 beats/min        1.21 (1.15 to 1.28)   1.13 (1.09 to 1.16)

100=£12; €13; \$14.

Discussion
==========

This large national survey indicated that 11.2% of adults (according to WHO criteria) or 12.8% of adults (ADA criteria including the addition of HbA~1c~) aged 18 and older living in China had diabetes in 2017. Thus the total number of patients with diabetes in mainland China is estimated to be 129.8 million (70.4 million men and 59.4 million women).

The prevalence of diabetes continues to increase worldwide. The Non-Communicable Disease Risk Factor Collaboration reported that the age standardised prevalence of adult diabetes is 10% in men and 8.8% in women.[@ref3] Between 1980 and 2014, the global prevalence of diabetes increased from 4.3% to 9.0% in men and from 5.0% to 7.9% in women.[@ref3] For the increase in the number of adults with diabetes, 28.5% was attributed to the increased prevalence, 39.7% to population growth and ageing, and 31.8% to both.[@ref3]

The trend in the prevalence of diabetes in China is the same as that worldwide. The weighted prevalence of total diabetes diagnosed by the WHO criteria has been increasing from 9.7% in 2007 and 2010, to 10.4% in 2013, and to 11.2% in this study in 2017 (supplementary table 4).[@ref11] [@ref12] [@ref13] The prevalence of prediabetes was 35.2%, which was similar to the 35.7% reported in 2013 with the same ADA diagnostic criteria.[@ref11] In this study, a venous blood was used to test for HbA~1c~, and this method was accepted by most laboratories. These findings suggest that the prevalence of total diabetes in China maintains a trend of continuing growth without any plateau or inflection point.

Awareness, treatment, and control of diabetes
---------------------------------------------

Although a continuing increase in self-reported diabetes was found, a decrease in the prevalence of newly diagnosed diabetes was noted under the same WHO diagnostic criteria (supplementary table 4), suggesting better awareness of diabetes than found in previous studies.[@ref11] [@ref12] [@ref13] This improved awareness could be attributed to the concerted effort of the China National Plan for Non-Communicable Diseases Prevention and Treatment in 2013-15 and the Chinese Diabetes Society's Diabetes Prevention and Management Program (Bluelight Action) from 2010.[@ref19] The percentage control of diabetes in the 2017 survey was improved in comparison with the 2010 survey but remained the same as in the 2013 survey, which indicates that the healthcare system needs further strengthening and improvement. Thus systematically trained community physicians with the requisite skills and expertise in diagnosis, management, and treatment of diabetes are needed to improve its control.

Age and age specific difference in the prevalence of diabetes
-------------------------------------------------------------

The prevalence of total diabetes and prediabetes was extremely high in people over 50, as was found in previous studies using the same ADA diagnostic criteria.[@ref12] [@ref13] Compared with previous data, the prevalence of total diabetes in the younger population was relatively low and decreasing, which is inconsistent with the concept that diabetes has a tendency to be greater among the young in Asia.[@ref20] Increases in the prevalence of total diabetes, diagnosed by the WHO criteria, have resulted from an increased prevalence in those aged 40 and older, especially the population older than 50 (supplementary table 5, supplementary fig 4).[@ref11] [@ref12] [@ref13] The age specific difference might partially explain the phenomenon. Many patients with prediabetes in the younger population have more social and family responsibilities but poorer health awareness. As a result, effective lifestyle modification or medical treatments are lacking in this population. Additionally, people who remain free from diabetes and prediabetes after the age of 50 might have some advantages due to genetic, socioeconomic, and lifestyle factors, and will continue to be healthier with ageing. One study showed that prenatal exposure to famine markedly increased the risk of hyperglycaemia in two consecutive generations of adults living in China.[@ref21] Given that the Chinese famine of 1959--61 was among the most severe on record, the affected population comprises those with a current age of 50 and older, who showed a higher prevalence of diabetes and prediabetes.[@ref22] Whether or not prenatal exposure to famine affects diabetes remains controversial, and this needs to be investigated in future studies.[@ref23]

Being overweight and obese
--------------------------

Obesity and being overweight are two important risk factors for diabetes, and changes in these factors could contribute to the changes in the prevalence of total diabetes.[@ref24] The prevalence of obesity increased from 5.7% in the 2010 survey to 6.3% in the 2017 survey.[@ref12] Waist circumference also increased significantly from 80.2 cm to 80.7 cm in the 2007 and 2010 surveys to 83.2 cm in the 2017 survey (no published data on the 2013 survey for waist circumference are yet available).[@ref11] [@ref12] An increase in mean values of waist circumference, and prevalence in general overweight and obesity, and central obesity from 2007 to 2017 could contribute to an increase in the prevalence of diabetes, although we found no changes in body mass index between the 2013 and 2017 surveys (supplementary table 4). Nevertheless, obesity is still an important risk factor for diabetes.

Genetic background and geography
--------------------------------

It is generally accepted that genetic factors significantly influence the risk of developing diabetes. Substantial differences in genetic background are present among certain ethnic groups in mainland China. This study found that the prevalence of total diabetes and prediabetes in four ethnic groups was significantly different from that in the Han ethnic group. Compared with the Han ethnic group, the Tibetan ethnic group had a significantly lower prevalence of diabetes, which was consistent with the findings of a previous study.[@ref13] The difference might be associated with dietary patterns, altitude, economic development, and genetic factors.[@ref25] [@ref26] A wide variation in the prevalence of diabetes and prediabetes between the Hui and Uyghur ethnic groups was found in this study. The difference might be explained by factors such as genetic variation, although the two minority groups in northwest China lived among Muslims and shared similar lifestyles.[@ref27] [@ref28]

Among the 31 provinces of mainland China, a large variation in the prevalence of diabetes and prediabetes was found. In Inner Mongolia, the prevalence of total diabetes was three times higher than that in Guizhou province. For prediabetes, Yunnan province had the highest prevalence, being three times higher than the lowest prevalence in Anhui province. Although few differences in the prevalence of total diabetes existed between regions, a considerable variation in awareness, treatment, and control of the disease was found. This difference might be associated with genetic factors, environmental factors, dietary patterns, level of medical care, lifestyle, and economic development levels. Therefore, appropriate allocation of medical resources should be a key priority for policymakers.

Urban-rural disparity
---------------------

Variations based on urbanisation were found in the prevalence of total diabetes and prediabetes, and in awareness, treatment, and control of diabetes. Although the prevalence of total diabetes continues to be higher in urban than in rural areas, without a significant difference, the gap showed a decreasing trend compared with previous data.[@ref11] [@ref12] [@ref13] Compared with the national study conducted in 2013, the current prevalence of diabetes increased by 1% in urban areas but by 2.5% in rural areas under the same ADA diagnostic criteria. China has a large rural population, and sanitation is lacking, thus an increased prevalence of diabetes in rural areas will lead to increased diabetic complications. Given the higher prevalence of prediabetes, and lower awareness, treatment, and control of diabetes, in rural populations, a large number of people are at risk of developing diabetes without the implementation of effective preventive measures.

Strengths of the study
----------------------

This study had several strengths. Firstly, this nationally representative epidemiological survey provided reliable data on the prevalence of total diabetes and prediabetes in mainland China by following a strict quality assurance and control protocol. We estimated the prevalence not only by using statistical methods to weight the results but also by recruiting individuals according to the composition by age and sex of each community and the urban-rural ratio, referring to the latest national census data, which may have provided more accurate results. Secondly, a similar study design and statistical methods to those used previously make our findings more comparable with historical data. Although lacking a high quality national cohort to estimate the incidence of diabetes, our findings could add value to the assessment of diabetes epidemics in mainland China. Lastly, our study also provides provincial and regional data on prevalence using the latest diagnostic criteria for diabetes.

Limitations of the study
------------------------

Our study also had some limitations. Firstly, we did not obtain information about the physical activity, dietary patterns, or alcohol consumption of participants, which reduced our ability to explore some risk factors. Secondly, using levels of 6.5% for HbA~1c~ to diagnose diabetes could be controversial since that level was set for the US population. Although geographic disparities might exist in HbA~1c~ levels, a consistent threshold was preferred across the study to enable comparison. Thirdly, owing to our study design, we could not distinguish between type 1 and type 2 diabetes. Fourthly, we did not carry out repeat testing in people with abnormal glucose values over time. We categorised one reading as being synonymous with diabetes, which may overestimate the prevalence, compared with clinical practice.[@ref29] Lastly, non-residents, such as internal migrant workers, who account for more than a sixth of the nation's total population in China and who were more likely to have a lower prevalence of diabetes, were not included in the study owing to the study design.[@ref30] [@ref31] These limitations could lead to an overestimation of diabetes in the population.

Conclusions and policy implications
-----------------------------------

In conclusion, the estimated prevalence of total diabetes and prediabetes diagnosed by the ADA criteria was 12.8% and 35.2%, respectively, among the Chinese population aged 18 and older between 2015 and 2017. The prevalence of total diabetes defined by the WHO criteria increased from 9.7% in 2007 to 11.2% in 2017 among adults living in China. Our findings indicate that diabetes is an important health problem in China. Continuing surveillance and effective control are needed to reduce its burden.

### What is already known on this topic

1.  The previous national survey of diabetes in China, conducted in 2013, found a diabetes prevalence of 10.9% and a prediabetes prevalence of 35.7% using the American Diabetes Association (ADA) diagnostic criteria

2.  In 2013, China implemented major healthcare reform and several government prevention, screening, and management programmes for non-communicable diseases, which provided useful data to show whether these changes have affected the prevalence of diabetes

3.  Such surveys generally use a single reading of glucose or HbA~1c~, rather than repeat readings which are typical in clinical practice, where clinical diagnosis is based also on patient symptoms

### What this study adds

1.  This nationally representative epidemiological survey indicated that the overall prevalence of diabetes in mainland China in 2017 was 12.8% using the ADA diagnostic criteria and 11.2% using World Health Organization criteria

2.  The prevalence of diabetes in 2017 in China is higher than that found by previous national surveys in 2007, 2010, and 2013 using the same WHO diagnostic criteria

3.  The findings suggest that diabetes is an important health problem in China
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